Fatigue News and Research

RSS

Levels of depression and anxiety are higher in people with severe rheumatoid arthritis

Levels of depression and anxiety in people with severe rheumatoid arthritis are higher than previously reported, according to new research. As a result of their findings, a multi-centre team led by researchers at the Arthritis Research UK Centre for Genetics and Genomics at the University of Manchester, say that patients with severe active disease, who are waiting to go onto a biological therapy, should be routinely screened for depression by their doctors.

From The University of Manchester 21 Jan 2014

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).

18 Jan 2014

Vitamin D may be adjunct for patients with fibromyalgia syndrome, say researchers

Patients with fibromyalgia syndrome (FMS) typically have widespread chronic pain and fatigue. For those with low vitamin D levels, vitamin D supplements can reduce pain and may be a cost-effective alternative or adjunct to other treatment, say researchers in the January 2014 issue of PAIN-.

17 Jan 2014

Urban police officers working night shift more likely to suffer long-term on-the-job injuries

Police officers working the night shift are significantly more likely to suffer long-term on-the-job injuries than officers on day and afternoon shifts, according to new research conducted at the University at Buffalo.

17 Jan 2014

BMC reduced audible alarms as a way to combat alarm fatigue, improve patient safety

Boston Medical Center (BMC) successfully reduced audible alarms as a way to combat alarm fatigue and improve patient safety. The hospital, one of two in the country that spearheaded this issue, implemented a novel cost-effective approach during a six-week pilot program that resulted in a drastic drop in audible alarms.

16 Jan 2014

New drug combination proves effective in treatment of hepatitis C

Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere.

16 Jan 2014

Study questions widely used method of diagnosing acute mountain sickness

A study led by University of British Columbia scientists calls into question a widely used method of diagnosing acute mountain sickness.

9 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

Norwegian researchers map genetic variations associated with increased risk of MS and MG

The Norwegian researchers have taken part in an international cooperative effort to map 110 genetic variations that increase the risk of MS and MG. Most of these genetic variations have been mapped in recent years.

9 Jan 2014

Mild electronic stimulation therapy to upper airway during sleep effective in reducing OSA

Results published in a new study in the Jan. 9 issue of the New England Journal of Medicine report that mild electronic stimulation therapy to the upper airway during sleep is effective in reducing obstructive sleep apnea (OSA).

9 Jan 2014

Implantation of sleep apnea device can lead to improvements for patients with OSA

Implantation of a sleep apnea device called Inspire- Upper Airway Stimulation therapy can lead to significant improvements for patients with obstructive sleep apnea, according to a study published today in the New England Journal of Medicine.

9 Jan 2014

Research opens door to new direction of PAH treatment

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.

8 Jan 2014

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.

7 Jan 2014

Food labeling, product placement intervention can promote healthy choices

The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice of more healthful food items among customers in a large hospital cafeteria. A Massachusetts General Hospital team reports in the American Journal of Preventive Medicine that the previously reported changes in the proportions of more and less healthy foods purchased in the months after their program began have persisted up to two years after the labeling intervention was introduced.

7 Jan 2014

Study shows link between nurse fatigue and clinical decision regret

Fatigued nurses are more likely to express concern that they made a wrong decision about a patient's care, according to a study in the January issue of American Journal of Critical Care (AJCC).

3 Jan 2014

Who do Americans want care from? Doctors or other practitioners?

Doctors who provide personalized care get organized into a new group while a new survey seems to suggest American prefer getting their care from a doctor instead of nurse practitioners or physician assistants.

24 Dec 2013

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

20 Dec 2013

Five tips to identify individuals who may be vulnerable during holidays

While it is true that suicide rates are actually lower at the holidays compared to other times of the year, the holidays can be a very lonely time for those with nowhere to go and no one to turn to.

20 Dec 2013

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

In a new study, scientists from University of Copenhagen document a connection between congenital arrhythmia and the bodies' ability to handle sugar. The results can be of vital importance for patients with the disease and for the future treatment of diabetes. The new study has just been published in the scientific journal Diabetes.

19 Dec 2013

New study aims to identify breast cancer patients most susceptible to post-treatment fatigue

Although the prevalence and impact of cancer-related fatigue has been well established, very little is known about its predictors, mechanisms for development, and persistence post-treatment. A new research study at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, in partnership with UCLA, is aimed at identifying breast cancer patients most susceptible to post-treatment fatigue by measuring biological, behavioral and social risk factors.

19 Dec 2013

Fatigue News and Research

Levels of depression and anxiety are higher in people with severe rheumatoid arthritis

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Vitamin D may be adjunct for patients with fibromyalgia syndrome, say researchers

Urban police officers working night shift more likely to suffer long-term on-the-job injuries

BMC reduced audible alarms as a way to combat alarm fatigue, improve patient safety

New drug combination proves effective in treatment of hepatitis C

Study questions widely used method of diagnosing acute mountain sickness

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Norwegian researchers map genetic variations associated with increased risk of MS and MG

Mild electronic stimulation therapy to upper airway during sleep effective in reducing OSA

Implantation of sleep apnea device can lead to improvements for patients with OSA

Research opens door to new direction of PAH treatment

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Food labeling, product placement intervention can promote healthy choices

Study shows link between nurse fatigue and clinical decision regret

Who do Americans want care from? Doctors or other practitioners?

Solana's CrossCHECK Plating System receives FDA clearance

Five tips to identify individuals who may be vulnerable during holidays

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

New study aims to identify breast cancer patients most susceptible to post-treatment fatigue

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News